Better Health Outcomes Through Mentoring and Assessment (BHOMA) (BHOMA)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01942278 |
Recruitment Status :
Completed
First Posted : September 13, 2013
Last Update Posted : April 14, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
BHOMA Interventions
The purpose of this study is to assess the impact of the BHOMA intervention on health in 3 rural districts of Zambia.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Patient Care | Other: BHOMA | Not Applicable |

Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 207517 participants |
Allocation: | Randomized |
Intervention Model: | Crossover Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Health Services Research |
Official Title: | CIDRZ 1229- Better Health Outcomes Through Mentoring and Assessment (BHOMA) |
Actual Study Start Date : | January 2011 |
Actual Primary Completion Date : | August 2016 |
Actual Study Completion Date : | August 2016 |
Arm | Intervention/treatment |
---|---|
No Intervention: Usual Care
Care is delivered according to baseline standard practice
|
|
Experimental: BHOMA
Care is delivered according to the BHOMA intervention
|
Other: BHOMA
A complex health systems, clinical care, and community intervention to improve outcomes |
- Age standardized mortality rates in those aged <60 years. [ Time Frame: 4 years ]The sample size is based on a mortality rate for those aged<60 years of 20/1000 person years, each of 3 cross sectional surveys recruits 150 households of whom 6 members are aged <60 years, and births and deaths within the household in the last 12 months are ascertained. For a values of k between 0.2 and 0.3 there is at least 90% power to detect a 35% reduction in mortality, and for k=0.35 there is approximately 87% power.
- Mortality in those aged <5 years. [ Time Frame: 4 years ]The sample size is based on a mortality rate for those aged<5 years of 35/1000 person years (equivalent to under-5 mortality of 168/1000), each of 3 cross sectional surveys recruits 150 households of whom 2 members are aged <5 years, and births and deaths within the household in the last 12 months are ascertained. For a values of k between 0.2 and 0.3 there is at least 90% power to detect a 35% reduction in mortality, and for k=0.35 there is approximately 84% power.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Older Adult |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Intervention Sites The intervention will involve all of the health facilities in the Chongwe, Kafue and Luangwa districts.
Exclusion Criteria Hospitals will be excluded from the intervention as they do not have discrete catchment populations. The intervention will be implemented by 6 teams each of which will use 1 facility as a pilot site to test out the intervention. The pilot sites will be excluded from the evaluation. Health facilities with catchment populations exclusively serving the armed forces will be excluded.
Inclusion Criteria
- All enumerated adults who are able to give written, informed consent. If an adult is illiterate they may be asked to give consent providing the information is read to them and it is established that they fully understand its contents and there is a witness available to witness the understanding of the information and the fingerprinting of the consent form.
- All adolescents 10-17 years and children 5 years or less who have a parent or responsible guardian who is able to give written, informed consent. If the parent or guardian is illiterate they may be asked to give consent providing the information is read to them and it is established that they fully understand its contents and there is a witness available to witness the understanding of the information and the fingerprinting of the consent form.
Exclusion Criteria
- Any adult who is unable to give informed consent due to mental or other disability
- Any adolescent or child who has no responsible parent or guardian
- Any household member who has been absent from the house for more than 72 hours

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01942278
Zambia | |
Center for Infectious Disease Research in Zambia | |
Lusaka, Zambia |
Principal Investigator: | Jeffrey Stringer, MD | UNC at Chapel Hill |
Responsible Party: | University of North Carolina, Chapel Hill |
ClinicalTrials.gov Identifier: | NCT01942278 |
Other Study ID Numbers: |
CIDRZ 1229 |
First Posted: | September 13, 2013 Key Record Dates |
Last Update Posted: | April 14, 2017 |
Last Verified: | February 2017 |
Healthcare Patients |